- Market Capitalization, $K 309,272
- Shares Outstanding, K 227,406
- Annual Sales, $ 30,110 K
- Annual Income, $ -580 K
- 60-Month Beta 1.41
- Price/Sales 10.42
- Price/Cash Flow N/A
- Price/Book 4.12
|Period||Period Low||Period High||Performance|
| || |
-0.4600 (-25.27%)since 06/25/21
| || |
-0.4700 (-25.68%)since 04/27/21
| || |
-0.7000 (-33.98%)since 07/27/20
/PRNewswire/ -- (Nasdaq: DRRX) today announced that it will report its second quarter 2021 financial results and host a conference call after the market close on .
/PRNewswire/ -- (Nasdaq: DRRX) today announced it will present at the , being held virtually July 13-15, 2021.
/PRNewswire/ -- (Nasdaq: DRRX) today announced the presentation of additional clinical data from a DUR-928 Phase trial in non-alcoholic steatohepatitis (NASH) and a Phase 1 trial in subjects with hepatic...
/PRNewswire/ -- (Nasdaq: DRRX) today announced it will present two posters at the 2021 to be held virtually , 2021.
The rising prevalence of chronic diseases such as a variety of cancers, osteoarthritis, stomach ulcer, chronic arthritis and diabetes are major key factor which drives the Global Pain Relief Therapeutics...
Durect (DRRX) delivered earnings and revenue surprises of 0.00% and -15.99%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
CUPERTINO, Calif. (AP) _ Durect Corp. (DRRX) on Tuesday reported a loss of $10.1 million in its first quarter.
, /PRNewswire/ -- (Nasdaq: DRRX) today announced financial results for the three months ended and provided a corporate update.
NEW YORK, NY / ACCESSWIRE / May 4, 2021 / DURECT Corp. (NASDAQ:DRRX) will be discussing their earnings results in their 2021 First Quarter Earnings call to be held on May 4, 2021 at 4:30 PM Eastern Time....
|3rd Resistance Point||1.4567|
|2nd Resistance Point||1.4333|
|1st Resistance Point||1.3967|
|1st Support Level||1.3367|
|2nd Support Level||1.3133|
|3rd Support Level||1.2767|